Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 29, 2017 - Issue 9
836
Views
26
CrossRef citations to date
0
Altmetric
Articles

Integrated opioid substitution therapy and HIV care: a qualitative systematic review and synthesis of client and provider experiences

, , , , , , , , , & show all
Pages 1119-1128 | Received 06 Oct 2016, Accepted 06 Feb 2017, Published online: 10 Mar 2017

References

  • Ambekar, A., Arumugam, V., Sharma, A., Raju, R., & Singh, S. (2014). Drug use patterns among clients recieving services from targeted interventions for people who inject drugs. Findings from Bihar, Haryana, Jamu and Uttarkhand. New Delhi: India HIV/AIDS Alliance.
  • Azim, T., Bontell, I., & Strathdee, S. A. (2015). Women, drugs and HIV. International Journal of Drug Policy, 26(Suppl. 1), S16–S21. doi:10.1016/j.drugpo.2014.09.003
  • Batchelder, A. W., Brisbane, M., Litwin, A. H., Nahvi, S., Berg, K. M., & Arnsten, J. H. (2013). “Damaging what wasn’t damaged already”: Psychological tension and antiretroviral adherence among HIV-infected methadone-maintained drug users. AIDS Care, 25(11), 1370–1374. doi:10.1080/09540121.2013.766303
  • Beyrer, C., Baral, S., Kerrigan, D., El-Bassel, N., Bekker, L.-G., & Celentano, D. D. (2011). Expanding the space: Inclusion of most-at-risk populations in HIV prevention, treatment, and care services. JAIDS Journal of Acquired Immune Deficiency Syndromes, 57(Suppl. 2), S96–S99. doi:10.1097/QAI.0b013e31821db944
  • Bojko, M. J., Mazhnaya, A., Makarenko, I., Marcus, R., Dvoriak, S., Islam, Z., & Altice, F. L. (2015). “Bureaucracy & beliefs”: Assessing the barriers to accessing opioid substitution therapy by people who inject drugs in Ukraine. Drugs: Education, Prevention and Policy, 22, 255–262. doi:10.3109/09687637.2015.1016397
  • Bourgois, P. (2000). Disciplining addictions: The biopolitics of methadone and heroin in the United States. Culture, Medicine and Psychiatry, 24, 165–195. doi:10.1023/A:1005574918294
  • Briggs, C., & Garner, P. (2006). Strategies for integrating primary health services in middle- and low-income countries at the point of delivery. The Cochrane Database of Systematic Reviews, 19(2), 1–22.
  • Broadhead, R., Heckathorn, D. D., Weakliem, D. L., Anthony, D. L., Madray, H., Mills, R. J., & Hughes, J. (1998). Harnessing peer networks as an instrument for AIDS prevention: Results from a peer-driven intervention. Public Health Reports, 113(Suppl. 1), 42–57.
  • Bruce, R. D., Lambdin, B., Chang, O., Masao, F., Mbwambo, J., Mteza, I., … Kilonzo, G. (2014). Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment. International Journal of Drug Policy, 25(1), 22–25. doi:10.1016/j.drugpo.2013.09.005
  • Chakrapani, V., Velayudham, J., Shunmugam, M., Newman, P. A., & Dubrow, R. (2014). Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India. Aids Care, 26(7), 835–841. doi: 10.1080/09540121.2013.861573
  • Conway, B., Prasad, J., Reynolds, R., Farley, J., Jones, M., Jutha, S., … Devlaming, S. (2004). Directly observed therapy for the management of HIV--infected patients in a methadone program. Clinical Infectious Diseases, 38, S402–S408. doi:10.1086/421404
  • Crawford, S. (2013). Shouting through bullet-proof glass: Some reflections on pharmacotherapy provision in one Australian clinic. International Journal of Drug Policy, 24(6), e14–e17. doi:10.1016/j.drugpo.2013.07.004
  • Critical Appraisal Skills Programme (CASP). (2015). 10 questions to help you make sense of qualitative research. Oxford: Better Value Healthcare. Retrieved from www.casp-uk.net
  • Curtis, M. (2009). Building integrated care for injection drug users in Ukraine. Denmark: World Health Organisation.
  • Daftary, A., Calzavara, L., & Padayatchi, N. (2015). The contrasting cultures of HIV and tuberculosis care. AIDS, 29(1), 1–4. doi:10.1097/QAD.0000000000000515
  • Degenhardt, L., Mathers, B. M., Wirtz, A. L., Wolfe, D., Kamarulzaman, A., Carrieri, M. P., … Beyrer, C. (2014). What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010–2012? A review of the six highest burden countries. International Journal of Drug Policy, 25(1), 53–60. doi:10.1016/j.drugpo.2013.08.004
  • Demchenko, I., Kozhan, N., Varban, M., & Kolomiets, V. (2014). A brief summary of operational findings: The study of access to HIV and TB treatment for substitution therapy patients within different service delivery models. Kiev: Alliance Ukraine.
  • Deshko, T. P. (2015). HIV reduction among women who inject drugs can be achieved through women-specific programs and global targets: A model from Ukraine. JAIDS Journal of Acquired Immune Deficiency Syndromes, 69(Suppl. 2), S98–S99. doi:10.1097/QAI.0000000000000622
  • Drainoni, M. L., Farrell, C., Sorensen-Alawad, A., Palmisano, J. N., Chaisson, C., & Walley, A. Y. (2014). Patient perspectives of an integrated program of medical care and substance use treatment. AIDS Patient Care and STDs, 28, 71–81. doi:10.1089/apc.2013.0179
  • Egan, J. E., Netherland, J., Gass, J., Finkelstein, R., Weiss, L., & Collaborative, B. (2011). Patient perspectives on buprenorphine/naloxone treatment in the context of HIV care. JAIDS Journal of Acquired Immune Deficiency Syndromes, 56(Suppl. 1), S46–53. doi:10.1097/QAI.0b013e3182097561
  • Fraser, S. (2006). The chronotope of the queue: Methadone maintenance treatment and the production of time, space and subjects. International Journal of Drug Policy, 17(3), 192–202. doi:10.1016/j.drugpo.2006.02.010
  • Glenton, C., Lewin, S., & Gülmezoglu, A. M. (2016). Expanding the evidence base for global recommendations on health systems: Strengths and challenges of the OptimizeMNH guidance process. Implementation Science, 11(1), 1–11. doi:10.1186/s13012-016-0470-y
  • Grenfell, P., Baptista Leite, R., Garfein, R., de Lussigny, S., Platt, L., & Rhodes, T. (2013). Tuberculosis, injecting drug use and integrated HIV-TB care: A review of the literature. Drug and Alcohol Dependence, 129, 180–209. doi:10.1016/j.drugalcdep.2012.11.013
  • Grenfell, P., Claudia Carvalho, A., Martins, A., Cosme, D., Barros, H., & Rhodes, T. (2012). A rapid assessment of the accessibilty and integration of HIV, TB and harm reduction services for people who inject drugs in Portugal. Copenhagen: World Health Organisation.
  • Harm Reduction International, International Drug Policy Consortium & International HIV/AIDS Alliance. (2014). The funding crisis for harm reduction. London: International Harm Reduction Association.
  • Harris, M., & Rhodes, T. (2013). Methadone diversion as a protective strategy: The harm reduction potential of ‘generous constraints’. International Journal of Drug Policy, 24(6), e43–e50. doi:10.1016/j.drugpo.2012.10.003
  • Islam, M. M., Topp, L., Day, C. A., Dawson, A., & Conigrave, K. M. (2012). The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: A narrative synthesis of literature. International Journal of Drug Policy, 23(2), 94–102. doi:10.1016/j.drugpo.2011.08.005
  • Jones, L., Atkinson, A., Bates, G., McCoy, E., Porcellato, L., Beynon, C., … Bellis, M. A. (2014). Views and experiences of hepatitis C testing and diagnosis among people who inject drugs: Systematic review of qualitative research. International Journal of Drug Policy, 25(2), 204–211. doi:10.1016/j.drugpo.2013.11.004
  • Keats, J., Micallef, M., Grebely, J., Hazelwood, S., Everingham, H., Shrestha, N., … Dunlop, A. (2015). Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, Australia. International Journal of Drug Policy, 26(10), 999–1006. doi:10.1016/j.drugpo.2015.07.006
  • Kennedy, C., Spaulding, A., Brickley, D., Almers, L., Mirjahangir, J., Packel, L., … Osborne, K. (2010). Linking sexual and reproductive health and HIV interventions: A systematic review. Journal of the International AIDS Society, 13(1), 26. doi:10.1186/1758-2652-13-26
  • Korthuis, P. T., Gregg, J., Rogers, W. E., McCarty, D., Nicolaidis, C., & Boverman, J. (2010). Patients’ reasons for choosing office-based buprenorphine: Preference for patient-centered care. Journal of Addiction Medicine, 4, 204–210. doi:10.1097/ADM.0b013e3181cc9610
  • Krüsi, A., Wood, E., Montaner, J., & Kerr, T. (2010). Social and structural determinants of HAART access and adherence among injection drug users. International Journal of Drug Policy, 21(1), 4–9. doi:10.1016/j.drugpo.2009.08.003
  • Lambdin, B. H., Mbwambo, J. K., Josiah, R. M., & Bruce, R. D. (2015). Service integration: Opportunities to expand access to antiretroviral therapy for people who inject drugs in Tanzania. Journal of the International AIDS Society, 18, 19936. doi:10.7448/IAS.18.1.19936
  • Leidel, S., Wilson, S., McConigley, R., Boldy, D., & Girdler, S. (2015). Health-care providers’ experiences with opt-out HIV testing: A systematic review. AIDS Care, 27, 1455–1467. doi:10.1080/09540121.2015.1058895
  • Lewin, S., Glenton, C., Munthe-Kaas, H., Carlsen, B., Colvin, C., Gulmezoglu, M., … Rashidian, A. (2015). Using qualitative evidence in decision making for health and social interventions: An approach to assess confidence in findings from qualitative evidence syntheses (GRADE-CERQual). PLOS Medicine, 12(10), e1001895. doi:10.1371/journal.pmed.1002065
  • Lin, C., Cao, X., & Li, L. (2014). Integrating antiretroviral therapy in methadone maintenance therapy clinics: Service provider perceptions. International Journal of Drug Policy, 25, 1066–1070. doi:10.1016/j.drugpo.2014.04.021
  • Low, A. J., Mburu, G., Welton, N. J., May, M. T., Davies, C. F., French, C., … Vickerman, P. (2016). Impact of opioid substitution therapy on antiretroviral therapy outcomes: A systematic review and meta-analysis. Clinical Infectious Diseases. doi:10.1093/cid/ciw416
  • Lucas, G. M., Mullen, B. A., Weidle, P. J., Hader, S., McCaul, M. E., & Moore, R. D. (2006). Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. Clinical Infectious Diseases, 42, 1628–1635. doi:10.1086/503905
  • Lucas, G. M., Weidle, P. J., Hader, S., & Moore, R. D. (2004). Directly administered antiretroviral therapy in an Urban methadone maintenance clinic: A nonrandomized comparative study. Clinical Infectious Diseases, 38, S409–S413. doi:10.1086/421405
  • MacArthur, G. J., Minozzi, S., Martin, N., Vickerman, P., Deren, S., Bruneau, J., … Hickman, M. (2012). Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis. BMJ, 345, e5945. doi:10.1136/bmj.e5945
  • Mathers, B., Degenhardt, L., Ali, H., Wiessing, L., Hickman, M., Mattick, R., … Strathdee, S. (2010). HIV prevention, treatment, and care services for people who inject drugs: A systematic review of global, regional, and national coverage. The Lancet, 375, 1014–1028. doi: 10.1016/S0140-6736(10)60232-2
  • McKeganey, N. (2011). Abstinence and harm reduction: Can they work together? International Journal of Drug Policy, 22(3), 194–195. doi:10.1016/j.drugpo.2011.04.001
  • Mimiaga, M. J., Safren, S. A., Dvoryak, S., Reisner, S. L., Needle, R., & Woody, G. (2010). “We fear the police, and the police fear us”: Structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine. AIDS Care, 22, 1305–1313. doi:10.1080/09540121003758515
  • Morrow, K., & Costello, T. (2004). HIV, STD and hepatitis prevention among women in methadone maintenance: A qualitative and quantitative needs assessment. AIDS Care, 16, 426–433. doi:10.1080/09540120410001683367
  • Noyes, J., & Lewin, S. (2011). Supplemental guidance on selecting a method of qualitative evidence synthesis, and integrating qualitative evidence with cochrane intervention reviews. In J. Noyes, A. Booth, K. Hannes, S. Harden, J. Harris, S. Lewin, & C. Lockwood (Eds.), Supplementary guidance for inclusion of qualitative research in Cochrane systematic reviews of interventions. Version 1 (updated August 2011). Cochrane Collaboration Qualitative Methods Group.
  • Pangaea Global AIDS Foundation. (2014 April). Consultative meeting on optimal models of care for people who inject drugs. Oakland, CA: Author.
  • Rance, J., & Treloar, C. (2015). “We are people too”: Consumer participation and the potential transformation of therapeutic relations within drug treatment. International Journal of Drug Policy, 26(1), 30–36. doi:10.1016/j.drugpo.2014.05.002
  • Reddon, H., Milloy, M. J., Simo, A., Montaner, J., Wood, E., & Kerr, T. (2014). Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users. AIDS and Behavior, 18, 740–746. doi:10.1007/s10461-013-0584-z
  • Rhodes, T., & Sarang, A. (2012). Drug treatment and the conditionality of HIV treatment access: A qualitative study in a Russian city. Addiction, 107, 1827–1836. doi: 10.1111/j.1360-0443.2012.03880.x
  • Ring, N., Ritchie, K., Mandava, L., & Jepson, R. (2011). A guide to synthesising qualitative research for researchers undertaking health technology assessments and systematic reviews. Stirling: NHS Quality Improvement Scotland.
  • Sarang, A., Rhodes, T., & Sheon, N. (2013). Systemic barriers accessing HIV treatment among people who inject drugs in Russia: A qualitative study. Health Policy and Planning, 28, 681–691. doi:10.1093/heapol/czs107
  • Strathdee, S. A., Hallett, T. B., Bobrova, N., Rhodes, T., Booth, R., Abdool, R., & Hankins, C. A. (2010). HIV and risk environment for injecting drug users: The past, present, and future. The Lancet, 376(9737), 268–284. doi:10.1016/S0140-6736(10)60743-X
  • Strauss, S. M., & Mino, M. (2011). Addressing the HIV-related needs of substance misusers in New York state: The benefits and barriers to implementing a “one-stop shopping” model. Substance Use & Misuse, 46, 171–180. doi:10.3109/10826084.2011.521465
  • Strike, C., Millson, M., Hopkins, S., & Smith, C. (2013). What is low threshold methadone maintenance treatment? International Journal of Drug Policy, 24(6), e51–e56. doi:10.1016/j.drugpo.2013.05.005
  • Sylla, L., Bruce, R. D., Kamarulzaman, A., & Altice, F. L. (2007). Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. International Journal of Drug Policy, 18(4), 306–312. doi:10.1016/j.drugpo.2007.03.001
  • Thomas, J., & Harden, A. (2008). Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Medical Research Methodology, 8, 22. doi:10.1186/1471-2288-8-45
  • Tobias, C., Drainoni, M. L., & McCree, J. (2000). Professional expert key informant report on HIV and substance abuse. Boston: Boston University School of Public Health.
  • Treloar, C., & Rance, J. (2014). How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting. International Journal of Drug Policy, 25, 865–870. doi:10.1016/j.drugpo.2014.01.011
  • Treloar, C., Rance, J., Bath, N., Everingham, H., Micallef, M., Day, C., … Dore, G. J. (2015). Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia. International Journal of Drug Policy, 26, 992–998. doi:10.1016/j.drugpo.2015.01.005
  • Treloar, C., & Rhodes, T. (2009). The lived experience of hepatitis C and its treatment among injecting drug users: Qualitative synthesis. Qualitative Health Research, 19, 1321–1334. doi:10.1177/1049732309341656
  • Tso, L. S., Best, J., Beanland, R., Doherty, M., Lackey, M., Ma, Q., … Tucker, J. D. (2016). Facilitators and barriers in HIV linkage to care interventions: A qualitative evidence review. AIDS, 30, 1639–1653. doi:10.1097/qad.0000000000001101
  • Tuthill, E., McGrath, J., & Young, S. (2014). Commonalities and differences in infant feeding attitudes and practices in the context of HIV in sub-Saharan Africa: A metasynthesis. AIDS Care, 26, 214–225. doi:10.1080/09540121.2013.813625
  • Uhlmann, S., Milloy, M. J., Kerr, T., Zhang, R., Guillemi, S., Marsh, D., … Wood, E. (2010). Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction, 105, 907–913. doi:10.1111/j.1360-0443.2010.02905.x
  • Uyei, J., Coetzee, D., Macinko, J., & Guttmacher, S. (2011). Integrated delivery of HIV and tuberculosis services in Sub-Saharan Africa: A systematic review. The Lancet Infectious Diseases, 11, 855–867. doi:10.1016/S1473-3099(11)70145-1
  • van Laere, I., Norviatin, D., Achmad, Y. M., Handayani, M., Indriasari, R., Istiqomah, A. R., … de Jong, C. (2010). The functioning of methadone maintenance treatment clinics in West Java, Indonesia: A baseline evaluation. Bandung/Nijmegen: RSHS, FK-UNPAD, Indonesia/NISPA, Radboud University, the Netherlands, Aids Fonds Program.
  • Weiss, L., Netherland, J., Egan, J. E., Flanigan, T. P., Fiellin, D. A., Finkelstein, R., … Collaborative, B. (2011). Integration of buprenorphine/naloxone treatment into HIV clinical care: Lessons from the BHIVES collaborative. JAIDS Journal of Acquired Immune Deficiency Syndromes, 56(Suppl. 1), S68–75. doi:10.1097/QAI.0b013e31820a8226
  • WHO & UNODC. (2009). Guidance on testing and counselling for HIV in settings attended by people who inject drugs: Improving access to treatment, care and prevention. Geneva: World Health Organisation.
  • WHO, UNODC, & UNAIDS. (2012). Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Geneva: World Health Organisation.
  • WHO. (2008). Technical brief No 1: Integrated health services – what and why? Geneva: World Health Organisation.
  • WHO. (2014). Consolidated guidelines on HIV prevention, diagnoses, treatment and care for key populations. Geneva: World Health Organisation.
  • Wolfe, D., Carrieri, M. P., & Shepard, D. (2010). Treatment and care for injecting drug users with HIV infection: A review of barriers and ways forward. The Lancet, 376, 355–366. doi:10.1016/S0140-6736(10)60832-X

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.